\
&
Contact us
\
&
Contact us
Partnership website: https://www.eppermed.eu/
The European Partnership for Personalised Medicine (EP PerMed) aims to align and promote regional and national priority setting and funding for research and implementation projects in the field of personalised medicine among the EU Member States, regions and beyond.
EP PerMed builds on over 15 years of EU-funded consortia, initiatives & events, but also on a wide range of national & European regional activities and efforts in all areas of the personalised medicine value continuum.
Grant Agreement negotiations for EP PerMed are ongoing. It is expected that the following Flemish partner organisations to participate in the Partnership:
| Belgium (Flanders) | Government of Flanders – Vlaams Gewest | https://www.vlaanderen.be/ |
| Belgium (Flanders) | Research Foundation – Flanders – Fonds Wetenschappelijk Onderzoek | https://www.fwo.be/en/ |
| Belgium (Flanders) | Flanders innovation & entrepreneurship – Fonds voor Innoveren en Ondernemen | https://www.vlaio.be/en |
Results will translate into delivery of better prevention and healthcare services, improved health outcomes for patients and citizens, and increased satisfaction with health systems.
Open & closed calls
A first joint transnational call for proposals under EP PerMed on "Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)" was launched in January 2024. The deadline for pre-proposals has passed. The result of the call for proposals is not expected before October 2024. First projects are expected to start end of 2024, beginning of 2025.
Information pages for stakeholders in Flanders:
- dedicated VLAIO webpage
- dedicated FWO webpage
You can register to EP PerMed's newsletter to be kept informed about future calls for proposals here.
Within EP PerMed, several earlier European Initiatives are joined under one roof. It will continue the activities of ERA PerMed in funding transnational innovation and research projects. In addition, EP PerMed will closely together with the International Consortium for Personalised Medicine ICPerMed for overarching strategic activities.
'ICPerMed Family' of Coordination and Support Actions:
Commission services: RTD-EP-PERSONALISED-MEDICINE@ec.europa.eu
The Partnership: eppermed@dlr.de
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The YoPA project, ‘a youth-centred preventive action approach towards co-created implementation of socially and physically activating environmental interventions’ obtained funding from Horizon Europe’s Health Cluster. The project addresses the multifaceted challenges of physical inactivity and health inequalities through a unique participatory approach. The project places teenagers between 12 and 18 years old in vulnerable situations at the forefront of the intervention process. The Institute of Tropical Medicine is a partner in the project and will conduct a Realist Evaluation to understand how youth co-creation contributes to improved adolescent health and well-being in four cities in Denmark, Netherlands, Nigeria and South Africa. By integrating its results and sharing its approach in an open access Toolbox, ITM aims to contribute to fostering sustainable, youth-led solutions for healthier urban environments.
